(Q37480878)

20 August 2017

1 reference

title

Current status of contrast-induced nephropathy and nephrogenic systemic fibrosis in children (English)

1 reference

contrast-induced nephropathy

20 August 2017

main subject

1 reference

nephrogenic systemic fibrosis

inferred from title

1 reference

inferred from title

author name string

Musturay Karcaaltincaba

series ordinal

1

1 reference

20 August 2017

Berna Oguz

series ordinal

2

1 reference

20 August 2017

Mithat Haliloglu

series ordinal

3

1 reference

20 August 2017

language of work or name

1 reference

1 June 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

39 Suppl 3

1 reference

20 August 2017

page(s)

382-384

1 reference

Current evidence on prevention and management of contrast-induced nephropathy

20 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00247-009-1236-3

Using a saline chaser to decrease contrast media in abdominal CT.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00247-009-1236-3

Gadolinium-enhanced multidetector CT angiography of the thoracoabdominal aorta.

21 January 2018

1 reference

12 December 2020

CT of pheochromocytoma and paraganglioma: risk of adverse events with i.v. administration of nonionic contrast material

1 reference

12 December 2020

Imatinib in the treatment of nephrogenic systemic fibrosis

1 reference

12 December 2020

Quality Initiatives MR Imaging in Patients at Risk for Developing Nephrogenic Systemic Fibrosis: Protocols, Practices, and Imaging Techniques to Maximize Patient Safety

1 reference

12 December 2020

Reducing the risk of iodine-based and MRI contrast media administration: recommendation for a questionnaire at the time of booking

1 reference

12 December 2020

Limited effects of UV-A1 phototherapy in 3 patients with nephrogenic systemic fibrosis

1 reference

12 December 2020

Clinical improvement of nephrogenic systemic fibrosis after kidney transplantation

1 reference

12 December 2020

Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

1 reference

12 December 2020

Nephrogenic systemic fibrosis

1 reference

12 December 2020

Contrast media toxicity in children

1 reference

12 December 2020

Which study when? Is gadolinium-enhanced MR imaging safer than iodine-enhanced CT?

1 reference

12 December 2020

Spurious hypocalcemia after Omniscan- or OptiMARK-enhanced magnetic resonance imaging: an algorithm for minimizing a false-positive laboratory value

1 reference

12 December 2020

Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging

1 reference

12 December 2020

Identifying outpatients with renal insufficiency before contrast-enhanced CT by using estimated glomerular filtration rates versus serum creatinine levels

1 reference

12 December 2020

Incidence of nephrogenic systemic fibrosis at two large medical centers

1 reference

12 December 2020

Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity

1 reference

12 December 2020

Pediatric abdominal CT angiography

1 reference

12 December 2020

Which study when? Iodinated contrast-enhanced CT versus gadolinium-enhanced MR imaging.

1 reference

12 December 2020

Hypoxia of the renal medulla--its implications for disease

1 reference

12 December 2020

Four- and eight-channel aortoiliac CT angiography: a comparative study

1 reference

12 December 2020

Combination of extremity computed tomography angiography and abdominal imaging in patients with musculoskeletal tumors.

1 reference

12 December 2020

Scleromyxoedema-like cutaneous diseases in renal-dialysis patients

1 reference

12 December 2020

Imatinib mesylate treatment of nephrogenic systemic fibrosis

1 reference

12 December 2020

Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities.

1 reference

12 December 2020

Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases

1 reference

12 December 2020

Treatment of nephrogenic systemic fibrosis with Re-PUVA.

1 reference

12 December 2020

Extracellular Gd-CA: differences in prevalence of NSF.

1 reference

12 December 2020

Nephrogenic systemic fibrosis associated with gadoversetamide exposure: treatment with sodium thiosulfate

1 reference

12 December 2020

Contrast-enhanced MR angiography of thoracic vascular malformations in children

1 reference

12 December 2020

Paediatric multidetector CT angiography: spectrum of congenital thoracic vascular anomalies.

1 reference

12 December 2020

Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue

1 reference

12 December 2020

Safety and efficacy of pressure-limited power injection of iodinated contrast medium through central lines in children

1 reference

12 December 2020

The need for radiologists' awareness of nephrogenic systemic fibrosis

1 reference

12 December 2020

Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose

1 reference

12 December 2020

Background fluctuation of kidney function versus contrast-induced nephrotoxicity

1 reference

12 December 2020

Reduction of contrast material dose and artifacts by a saline flush using a double power injector in helical CT of the thorax

1 reference

12 December 2020

IV contrast administration for CT: a survey of practices for the screening and prevention of contrast nephropathy

1 reference

12 December 2020

What is the normal serum creatinine concentration in children?

1 reference

12 December 2020

Nephrogenic fibrosing dermopathy in pediatric patients

1 reference

12 December 2020

Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients

1 reference

12 December 2020

Gadodiamide administration causes spurious hypocalcemia

1 reference

12 December 2020

Nephrogenic systemic fibrosis: risk factors and incidence estimation.

1 reference

12 December 2020

10.1007/S00247-009-1236-3

Identifiers

DOI

1 reference

20 August 2017

1 reference